skip to main content
Idioma:
Tipo de recurso Mostra resultados com: Mostra resultados com: Índice

Empagliflozin Inhibits Proximal Tubule NHE3 Activity, Preserves GFR, and Restores Euvolemia in Nondiabetic Rats with Induced Heart Failure

Borges-Júnior, Flávio A ; Silva Dos Santos, Danúbia ; Benetti, Acaris ; Polidoro, Juliano Z ; Wisnivesky, Aline C T ; Crajoinas, Renato O ; Antônio, Ednei L ; Jensen, Leonardo ; Caramelli, Bruno ; Malnic, Gerhard ; Tucci, Paulo J ; Girardi, Adriana C C

Journal of the American Society of Nephrology, 2021-07, Vol.32 (7), p.1616-1629 [Periódico revisado por pares]

United States: American Society of Nephrology

Texto completo disponível

Citações Citado por
  • Título:
    Empagliflozin Inhibits Proximal Tubule NHE3 Activity, Preserves GFR, and Restores Euvolemia in Nondiabetic Rats with Induced Heart Failure
  • Autor: Borges-Júnior, Flávio A ; Silva Dos Santos, Danúbia ; Benetti, Acaris ; Polidoro, Juliano Z ; Wisnivesky, Aline C T ; Crajoinas, Renato O ; Antônio, Ednei L ; Jensen, Leonardo ; Caramelli, Bruno ; Malnic, Gerhard ; Tucci, Paulo J ; Girardi, Adriana C C
  • Assuntos: Basic Research
  • É parte de: Journal of the American Society of Nephrology, 2021-07, Vol.32 (7), p.1616-1629
  • Notas: ObjectType-Article-1
    SourceType-Scholarly Journals-1
    ObjectType-Feature-2
    content type line 23
    F.A.B.-J. and D.S.d.S. contributed equally to this work.
  • Descrição: SGLT2 inhibitors reduce the risk of heart failure (HF) mortality and morbidity, regardless of the presence or absence of diabetes, but the mechanisms underlying this benefit remain unclear. Experiments with nondiabetic HF rats tested the hypothesis that the SGLT2 inhibitor empagliflozin (EMPA) inhibits proximal tubule (PT) NHE3 activity and improves renal salt and water handling. Male Wistar rats were subjected to myocardial infarction or sham operation. After 4 weeks, rats that developed HF and sham rats were treated with EMPA or untreated for an additional 4 weeks. Immunoblotting and quantitative RT-PCR evaluated SGLT2 and NHE3 expression. Stationary microperfusion measured PT NHE3 activity. EMPA-treated HF rats displayed lower serum B-type natriuretic peptide levels and lower right ventricle and lung weight to tibia length than untreated HF rats. Upon saline challenge, the diuretic and natriuretic responses of EMPA-treated HF rats were similar to those of sham rats and were higher than those of untreated HF rats. Additionally, EMPA treatment prevented GFR decline and renal atrophy in HF rats. PT NHE3 activity was higher in HF rats than in sham rats, whereas treatment with EMPA markedly reduced NHE3 activity. Unexpectedly, SGLT2 protein and mRNA abundance were upregulated in the PT of HF rats. Prevention of HF progression by EMPA is associated with reduced PT NHE3 activity, restoration of euvolemia, and preservation of renal mass. Moreover, dysregulation of PT SGLT2 may be involved in the pathophysiology of nondiabetic HF.
  • Editor: United States: American Society of Nephrology
  • Idioma: Inglês
Links
Voltar para lista de resultados
Ir para página anteriorAnterior Resultado  4 AvançarIr para próxima página

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.